PubMed · 6132154
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
E Ritz. 1983-04-09. Diagnosing prostatitis.. https://doi.org/10.1016/s0140-6736(83)91877-9
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
Nosocomial urinary infection complicating permanent probing is not an inverifiable inevitability. Analysis of simple physiopathological mechanisms lead to safety tactical forming an association with probing protocol and management of vesical taping line with enclosed method like a pernickety management of cleaning and changing.
Of 168 urine sediments, which were obtained from 55 patients with chronic pyelonephritis in the course of 3 years when a significant bacteriuria with E. coli was present, we demonstrated antibody-coated bacteria in 81 cases (48.21%). In the active stage of the disease with 54.10% were found significantly more than in the inactive with 32.61%. In obstructive chronic pyelonephritis the positive rate was 54.79% in contrast to 43.16% in non-obstructive chronic pyelonephritis. While in the active stage of the obstructive chronic pyelonephritis with 57.41% more antibody-coated bacteria were excreted only ACB+-, 34.29% only ACB-- and 40% ACB+- and ACB--germs in the course of the disease. The ACB-positive quote was in rough forms with 62.50% statistically significantly increased in contrast to 45.54% in O-typable and 42.86% in non-O-typable strains. In the ACB+-group the immunofluorescence titres to the homologous strain and the C3-activator in the serum as well as the urine lysozyme were significantly higher than in the ACB--group.
Urinary tract infection is the commonest human bacterial infection. Bacteriuria alone does not appear to produce progressive renal damage or hypertension. However, it can produce considerable morbidity. Urinalysis is a simple, relatively sensitive, and reliable way of diagnosing urinary tract infection. It is not clear that routine screening should be performed in all patients, but pregnant females, patients with known anatomic abnormalities, and patients with recent genitourinary instrumentation should be screened. The major determinant of therapeutic success in patients with urinary tract infections is the anatomic site of infection. Superficial mucosal infection of the bladder is well treated with a single dose of an appropriate antibiotic, whereas deep tissue infection of the kidney or prostate should be treated with a prolonged and intensive course of therapy. Urinalysis is an insensitive tool in the localization of infection. However, the presence of white cell casts on the examination of the urinary sediment is pathognomonic of upper tract infection and would lead one to pursue an aggressive course of therapy. Examination of the concentrating ability is of limited help in this regard because of the wide range of overlap of concentrating ability in patients with upper and lower tract infections. In selected instances, urinalysis is of help in guiding therapy of urinary tract infections. This is particularly true of the patients with acute urethral syndrome where therapy is guided by the presence or absence of pyuria. Urinalysis, a simple front-line test, is of paramount importance in the evaluation and management of the patient with urinary tract infection.